Stay updated on Pembrolizumab in Untreated B-Cell NHL Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Untreated B-Cell NHL Clinical Trial page.

Latest updates to the Pembrolizumab in Untreated B-Cell NHL Clinical Trial page
- Check4 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, representing a small update to the page metadata.SummaryDifference0.1%

- Check11 days agoChange DetectedThe page’s revision tag was updated from v3.6.0 to v3.6.2, indicating an internal update to the page. This does not modify the displayed study information, eligibility criteria, or results.*SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe study page now includes a recruitment status note indicating recruitment is closed ('No longer looking for participants'), and adds new user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) with an updated Intervention/Treatment label. The previous label 'Intervention / Treatment' and the older 'Revision: v3.5.5' are removed and replaced with 'Revision: v3.6.0'.SummaryDifference0.6%

- Check32 days agoChange DetectedRevision: v3.5.5 appears to replace v3.5.4 in the page metadata, signaling a small update to the page's revision history.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page shows a new revision number (v3.5.4) replacing v3.5.3, indicating a small site update. This change affects metadata rather than any study details.SummaryDifference0.1%

- Check75 days agoChange DetectedThe page’s footer revision/version has been updated from v3.5.2 to v3.5.3 for the ClinicalTrials.gov site software.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Untreated B-Cell NHL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Untreated B-Cell NHL Clinical Trial page.